-0.75 | -0.55%
| Price and Volume | |
|---|---|
| Recent Price | 136.00 |
| 52 Week High | 145.04 |
| 52 Week Low | 42.83 |
| Avg. Daily Vol. (Mil) | 0.85 |
| Beta (3 year) | 0.97 |
| Share Related Items | |
| Mkt Cap (Mil) | 12,652.47 |
| Shares Out (Mil) | 95.12 |
| Float (Mil) | 51.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.20 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.87 |
| Total Debt / Equity | 0.87 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 22.88 |
| Price/Book | 25.67 |
| Price/Cash Flow | -96.40 |
| Per Share Data | |
| Earnings | -1.84 |
| Sales | 5.94 |
| Book Value | 5.30 |
| Cash Flow | -1.41 |
| Business Summary | |
|---|---|
| Regeneron Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of therapeutics to treat human disorders and conditions. | |
| General Information | |
| 777 Old Saw Mill River Road
Tarrytown, NY 10591-6707 |
|
| www.regn.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1704 | |
| CEO: Dr. Leonard S. Schleifer | |
| Short Interest | |
| Current Month (Mil) | 5.11 |
| Previous Month (Mil) | 5.24 |
| Short Interest Ratio (Days) | 5.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -12.30 |
| Return on Investments | -17.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -24.60 |
| Profit Margin | -29.50 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,424.97 | 1,314.89 | 2,830.76 | 16.47 |
Oil *
103.33
|
|
DOWN
155.72 |
DOWN
17.53 |
DOWN
40.23 |
DOWN
0.84 |
10 Yr
1.65%
SPDR Gold
149.58
|
|
-1.24%
|
-1.32%
|
-1.40%
|
-4.85%
|
Data delayed 20 minutes |
Connect with TheStreet